首页> 外国专利> METHOD OF ESTIMATION OF CLINICAL EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY OF BLADDER CANCER

METHOD OF ESTIMATION OF CLINICAL EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY OF BLADDER CANCER

机译:膀胱癌新辅助化疗的临床疗效评估方法

摘要

FIELD: medicine.;SUBSTANCE: estimation of clinical effectiveness of neoadjuvant chemotherapy of bladder cancer is ensured by urine sampling from the bladder filled for 3 hours to determine the urine UBC marker level at the primary diagnosis stage and 1 month after preoperative chemotherapy. If observing the UBC level decreasing by 30% and more from the initial value, a partial regress of tumour is detected, while the UBC level reduced or increased to 29 % shows the stabilisation process, and the UBC level increasing by 30 % and more from the initial value enables to detect progression of the tumour process.;EFFECT: use of the method ensures more efficient estimation of neoadjuvant chemotherapy of bladder cancer.;1 tbl, 3 ex
机译:领域:医学;目的:通过在初次诊断阶段和术前化疗后1个月从装满膀胱的膀胱进行3小时尿液测定以确定尿UBC标记水平,以确保评估膀胱癌新辅助化疗的临床效果。如果观察到UBC水平从初始值降低30%或更多,则表明肿瘤部分消退,而UBC水平降低或增加到29%则表明稳定过程,而UBC水平从30%升高或更高。效果:使用该方法可确保更有效地估计膀胱癌的新辅助化疗。1tbl,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号